Detalhe da pesquisa
1.
Efficacy of preexposure prophylaxis with monoclonal-antibody tixagevimab-cilgavimab against emerging SARS-CoV-2 resistant variants in patients with chronic lymphocytic leukemia.
Acta Haematol
; 2024 Mar 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38471491
2.
[CHIMERIC ANTIGEN RECEPTOR T CELLS (CAR-T CELLS) THERAPY FOR B-CELL HEMATOLOGICAL MALIGNANCIES - FROM THE ISRAELI SOCIETY OF HEMATOLOGY AND TRANSFUSION MEDICINE].
Harefuah
; 163(4): 236-243, 2024 Apr.
Artigo
em Hebraico
| MEDLINE | ID: mdl-38616634
3.
CXCL12 secretion by bone marrow stromal cells is dependent on cell contact and mediated by connexin-43 and connexin-45 gap junctions.
Nat Immunol
; 12(5): 391-8, 2011 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-21441933
4.
Second hematopoietic stem cell transplantation as salvage therapy for relapsed acute myeloid leukemia/myelodysplastic syndromes after a first transplantation.
Haematologica
; 108(7): 1782-1792, 2023 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36475520
5.
The occurrence of thrombosis during intensive chemotherapy treatment for acute myeloid leukemia patients does not impact on long-term survival.
Ann Hematol
; 102(5): 1037-1043, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-36905445
6.
Cellular and humoral response to the fourth BNT162b2 mRNA COVID-19 vaccine dose in patients with CLL.
Eur J Haematol
; 110(1): 99-108, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36208015
7.
Defining Current Patterns of Blood Product Use during Intensive Induction Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia Patients.
Transfus Med Hemother
; 50(5): 456-468, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37899992
8.
Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in haematopoietic stem cell transplantation recipients.
Br J Haematol
; 196(4): 884-891, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34713441
9.
Safety and efficacy of the BNT162b mRNA COVID-19 vaccine in patients with chronic lymphocytic leukemia.
Haematologica
; 107(3): 625-634, 2022 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34320789
10.
ELN 2017 classification significantly impacts the risk of early death in acute myeloid leukemia patients receiving intensive induction chemotherapy.
Ann Hematol
; 101(2): 309-316, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34989829
11.
Evaluating outcomes of adult patients with acute lymphoblastic leukemia and lymphoblastic lymphoma treated on the GMALL 07/2003 protocol.
Ann Hematol
; 101(3): 581-593, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-35088172
12.
Polatuzumab-based regimen or CAR T cell for patients with refractory/relapsed DLBCL-a matched cohort analysis.
Ann Hematol
; 101(4): 755-762, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-35083525
13.
Contemporary evaluation of acute myeloid leukemia patients with long-term survival exceeding 5 years.
Eur J Haematol
; 109(6): 765-771, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36128925
14.
Imaging of Hematological Patients in the Era of COVID-19.
Acta Haematol
; 145(3): 267-274, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35100592
15.
A phase II study of bisantrene in patients with relapsed/refractory acute myeloid leukemia.
Eur J Haematol
; 106(2): 260-266, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-33159365
16.
Multiple Myeloma Presenting in Patients Younger than 50 Years of Age: A Single Institution Experience.
Acta Haematol
; 144(1): 58-65, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-32512574
17.
Safety and efficacy of allogeneic hematopoietic stem cell transplant after PD-1 blockade in relapsed/refractory lymphoma.
Blood
; 129(10): 1380-1388, 2017 03 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28073785
18.
Romidepsin treatment for relapsed or refractory peripheral and cutaneous T-cell lymphoma: Real-life data from a national multicenter observational study.
Hematol Oncol
; 37(5): 569-577, 2019 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-31674027
19.
Systemic Exposure of Rituximab Increased by Ibrutinib: Pharmacokinetic Results and Modeling Based on the HELIOS Trial.
Pharm Res
; 36(7): 93, 2019 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31044267
20.
Efficacy of Gemcitabine as Salvage Therapy for Relapsed and Refractory Aggressive Non-Hodgkin Lymphoma.
Acta Haematol
; 141(2): 84-90, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30630175